Ashish Deshmukh to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Ashish Deshmukh has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.041
-
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA. Pharmacoeconomics. 2023 Jun; 41(6):709-718.
Score: 0.041